Showing results (201-210 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|June 12, 2026
Development of a Machine Learning‑Based Prognostic Model for Intermediate Trophoblastic Tumors: A Single-Center Study With Web-Based Tool ImplementationWeidi Wang, Yunshu Jiao, Yuan Li, et al.
JCO Precision Oncology|June 3, 2026
ErbB Receptor Feedback Inhibitor 1 Mutation in Biliary Tract Cancers: Turning Resistance Into ResponseSupriya Peshin, Fen Saj, Pashtoon M Kasi, et al.
JCO Precision Oncology|June 8, 2026
Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid CarcinomaDavid Milewski, Arwa Fallatah, Maya Groff, et al.
JCO Precision Oncology|March 30, 2026
Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite InstabilityMohammad Jad Moussa, Alexander Y Andreev-Drakhlin, Aradhana M Venkatesan, et al.
JCO Precision Oncology|March 30, 2026
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung CancersEmily A Miao, Beow Yeap, Sameh Daher, et al.
JCO Precision Oncology|April 30, 2026
Lipidomic Predictors of Paclitaxel-Induced Peripheral NeuropathyYaping Liu, Ciao-Sin Chen, Nam Nguyen-Hoang, et al.
JCO Precision Oncology|April 23, 2026
Comparative Analysis of BRCA Pathogenic Variant Detection in a Real-World Setting: Population Screening Versus Oncogenetic ClinicsShunit Armon, Sari Lieberman, Rachel Michaelson-Cohen, et al.
JCO Precision Oncology|May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel TrialAndrew J Armstrong, Fred Saad, Mototsugu Oya, et al.
JCO Precision Oncology|May 6, 2026
Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision OncologyVai S Pathak, Courtney E Hershberger, Suneel Kamath, et al.
JCO Precision Oncology|March 5, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language ModelsS Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski, et al.
Pageof 140